Smoking during pregnancy and newborn neurobehavior

Pediatrics

Volumn 111, Issue 6 I, 2003, Pages 1318-1323

  Law, Karen L ^a   Stroud, Laura R ^b   LaGasse, Linda L ^c   Niaura, Raymond ^b   Liu, Jing ^c   Lester, Barry M ^c  

^a BROWN UNIVERSITY   (United States)

^b MIRIAM HOSPITAL   (United States)

^c WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Cotinine; Dose response; Neurobehavior; Pregnancy; Smoking

Indexed keywords

COTININE; NICOTINE;

ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; MATERNAL WELFARE; NERVE CELL EXCITABILITY; NEUROTOXICITY; NEWBORN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; SALIVA LEVEL; SELF REPORT; SMOKING; STRESS; VISUAL STIMULATION; ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM; CHEMISTRY; CHILD BEHAVIOR; CHILD DEVELOPMENT; CLASSIFICATION; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FEMALE; FETOMATERNAL TRANSFUSION; MOTHER; PRENATAL DEVELOPMENT; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SALIVA; SELF DISCLOSURE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM; CHILD DEVELOPMENT; COTININE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HUMANS; INFANT BEHAVIOR; INFANT, NEWBORN; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MOTHERS; NEONATAL ABSTINENCE SYNDROME; NICOTINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; SALIVA; SELF DISCLOSURE; SMOKING;

EID: 0037978066     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.111.6.1318     Document Type: Article

References (45)

1. Centers for Disease Control and Prevention. Women and Smoking: A Report of the Surgeon General. Washington, DC: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001
2. Matthews TJ. Smoking during pregnancy in the 1990s. Natl Vital Stat Rep. 2001;49(7):1-14
3. Substance Abuse and Mental Health Services Administration (SAM-HSA). National Household Survey on Drug Abuse (NHSDA). Bethesda, MD: National Institute on Drug Abuse; 1999
4. Jacobson SW, Jacobson JL, Sokol RJ, Martier SS, Chiodo LM. New evidence for neurobehavioral effects of in utero cocaine exposure. J Pediatr. 1996;129:581-590
5. Guyer B, Hoyert DL, Martin JA, Ventura SJ, MacDorman, MF, Strobino DM. Annual summary of vital statistics - 1998. Pediatrics. 1999;104:1229-1246
6. Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatol. 2000;5:231-241
7. Suzuki K, Minei LJ, Johnson EE. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol. 1980;136:1009-1013
8. Ganapathy V, Prasad PD, Ganapathy ME, Leibach FH. Drugs of abuse and placental transport. Adv Drug Deliv Rev. 1999;38:99-110
9. Levin ED, Slotkin TA. Developmental neurotoxicity of nicotine. In: Slikker W, Chang LW, eds. Handbook of Developmental Neurotoxicity. Academic Press; 1998:587-615
10. Slotkin TA. Fetal nicotine or cocaine exposure: Which one is worse? J Pharmacol Exp Ther. 1998;285:931-945
11. Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol. 1996;20:115-126
12. Nau H, Hansen R, Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther. 1985;8:384-395
13. Brazelton TB. Neonatal behavioral assessment scale. Clin Dev Med. London, United Kingdom: Spastics International Medical Publications; 1973:50
14. Jacobson SW, Fein GG, Jacobson JL, Schwartz P, Dowler J. Neonatal correlates of prenatal exposure to smoking, caffeine and alcohol. Infant Behav Dev. 1984;7:253-265
15. Richardson GA, Day NL, Taylor PM. The effect of prenatal alcohol, marijuana, and tobacco exposure on neonatal behavior. Infant Behav Dev. 1989;12:199-209
16. Saxton DW. The behaviour of infants whose mothers smoke in pregnancy. Early Hum Dev. 1978;2:363-369
17. Oyemade UJ, Cole OJ, Johnson AA, et al. Prenatal substance abuse and pregnancy outcomes among African American women. J Nutr 1994;124(6 suppl):994S-999S
18. Espy KA, Riese ML, Francis DJ. Neurobehavior in preterm neonates exposed to cocaine, alcohol and tobacco. Infant Behav Dev. 1997;20:297-309
19. Nugent JK, Lester BM, Greene SM, Wieczorek Deering D, O'Mahony P. The effects of maternal alcohol consumption and cigarette smoking during pregnancy on acoustic cry analysis. Child Dev. 1996;67:1806-1815
20. Boukydis CFZ, Lester BM. The NICU Network Neurobehavioral Scale: clinical use with drug exposed infants and their mothers. In: Lester BM, ed. Clinics in Perinatology. Philadelphia, PA: WB Saunders Co; 1999:213-230
21. Brown RA, Burgess E, Sales SD, et al. Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav. 1998;12:101-112
22. Gottfried AW. Measures of socioeconomic status in child development research: data and recommendations. Merrill Palmer Q. 1985;31:85-92
23. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, et al. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987;77:1435-1438
24. Donnenfeld AE, Pulkkinen A, Palomaki GE, et al. Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am J Obstet Gynecol. 1993;168(3, pt 1):781-782
25. Lester BM, Tronick EZ, Mayes L, et al. Neurodevelopmental consortium, the NICHD Neonatal research network. A neurodevelopmental follow-up battery for substance exposed infants. Pediatr Res. 1994;35
26. Lester BM, Tronick EZ. Behavioral assessment scales: The NICU Network Neurobehavioral Scale, the Neonatal Behavioral Assessment Scale, and the assessment of the perterm infant's behavior. In: Singer LT, Zeskind PS, eds. Biobehavioral Assessment of the Infant. New York, NY: The Guilford Press; 2001:363-380
27. Napiorkowski B, Lester BM, Freier MC, et al. Effects of in utero substance exposure on infant neurobehavior. Pediatrics. 1996;98:71-75
28. Lester BM, Tronick EZ, LaGasse LL, et al. The Maternal Lifestyle Study: effects of substance exposure during pregnancy on neurodeveopmental outcome in 1-month-old infants. Pediatrics. 2002;110:1182-1192
29. Ferguson A, Coyle M, LaGasse L, Liu E, Lester B. Neurobehavioral effects of treatment for opiate withdrawal [abstract]. Pediatr Res. 2001;49:18
30. Johnson RE, Jones HE, Jasinski DR, et al. Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug Alcohol Depend. 2001;63:97-103
31. Brazelton TB. Neonatal Behavioral Assessment Scale. Philadelphia, PA: JB Lippinicott; 1984
32. Finnegan LP. Neonatal abstinence syndrome: Assessment and pharmacotherapy. In: Rubatelli FF, Granati B, ed. Neonatal Therapy and Update. New York, NY: Experta Medica; 1986:122-146
33. Fried PA, Makin JE. Neonatal behavioral correlates of prenatal exposure to marijuana, cigarettes and alcohol in a low risk population. Neurotoxicol Teratol. 1987;10:305-313
34. Lassen K, Tian PSO. Effects of maternal cigarette smoking during pregnancy on long-term physical and cognitive parameters of child development. Addict Behav. 1998;23:635-653
35. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry. 1996;153:1138-1142
36. Benowitz JP. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 1994;56:483-493
37. Ostrea EM Jr, Brady MJ, Parks PM, Asensio DC, Naluz A. Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing. J Pediatr. 1989;115:474-477
38. US Department of Health and Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services; 1990:367-423
39. Brunnemann K, Hoffman D. Analytical studies on tobacco specific N nitrosamines in tobacco and tobacco smoke. Crit Rev Toxicol. 1991;21:235-240
40. Kramer MS. Intrauterine growth and gestational duration determinants. Pediatrics. 1987;80:502-511
41. Kramer MS. Socioeconomic determinants of intrauterine growth retardation. Eur J Clin Nutr. 1998;52(suppl 1):529-533
42. Pershagen G. Accumulating evidence on health hazards of passive smoking. Acta Paediatr. 1999;88:490-492
43. Ostrea EM, Morales V, Ngougmgna E. Use of Biological Markers in Assessing Drug Abuse. Bethesda, MD: NIDA Resource Center for Health Services Research; 1997
44. American Academy of Pediatrics, Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776-789
45. American Academy of Pediatrics, Committee on Substance Abuse. Tobacco's toll: implications for the pediatrician. Pediatrics. 2001;107:794-798